Discover Great Companies Discover Great Clients
Popularity  10.3万   |   Followers  58   |   Likes  62   |   Feedback  72 Claim this company

A well-known listed company in rapid diagnostic reagents (POCT), ranke

No.243 Wuhan City Popularity Ranking No.101 East Lake High-tech Zone No.344 Hubei Prov No.1 Kits No.1 Yi Liao Qi Xie Zhi Zao / Production No.1 Testing Reagents No.2 Analytical Instruments No.2 Ti Wai Diagnostics No.2 Pets Services No.3 Zhen Duan Yong Yao No.4 Antibodies No.4 Instrument Equipment No.4 Biotechnology Chemistry No.4 Diagnostic Reagents No.5 Reagents 企业技术中心 瞪羚企业 国家高新技术企业 高新技术企业 国家企业技术中心 专精特新小巨人企业 ISO13485认证 CE认证
More

Company Overview

  • Nature: Listed Company Size: 1000-4999 employees Founded: 18年
  • Industry: Pharmaceutical/Biotechnology 、 Medical Equipment/Devices
  • Full name: Wuhan EasyDiagnosis Biomedicine Co., Ltd.。

Development Stage

  • Stage: IPO上市, 主板, 深交所。
  • Ranking: Ranked #243 in Wuhan City by popularity Ranked #1 in Wuhan Kits Company by popularity Ranked #1 in Wuhan Yi Liao Qi Xie Zhi Zao / Production Company by popularity Ranked #1 in Wuhan Testing Reagents Company by popularity Ranked #2 in Wuhan Analytical Instruments Company by popularity
  • Honors: 2022中国新经济500强 2023中国高新技术企业慈善公益500强 企业技术中心 瞪羚企业 According to algorithm
  • News: 2023-07-13:明德生物:上半年净利同比预降95.29%-96.38%。
  • Salary: 54.6% of positions earn 10-20K, In 2026 vs last yeardecreased by 16%.。Master's salary: ¥21.1K, Doctorate salary: ¥25.0K.
  • R&D: "Electronics/Electrical/Communication Technology" demand: 8.4%, "Other (R&D and Technical)": 5.6%, "Computer/Network/Technology": 3.5%。
  • Recruiting: In 2026 vs 2025grew by 2%. Demand for highly educated talent: Master's: 4.
  • Requirement: Education: 本科 leads with 79.9%. Experience: 不限 leads with 34.6%.
  • Region: Distributed across 3 regions, 武汉: 69.2%, 长沙: 8.2%, 广州: 5%, 北京: 3.1%.

About the Company

[Summary] A well-known listed company in rapid diagnostic reagents (POCT), ranke

Wuhan EasyDiagnosis Biomedicine Co., Ltd. (002932.SZ) was founded in 2008 and is located in the National Bio-Industry Base – Wuhan Optics Valley Biolake. It is a national high-tech enterprise specialized in providing in vitro diagnostic reagents and supporting instruments (POCT, molecular diagnostics, chemiluminescence, blood gas analysis, etc.) as well as medical services such as chest pain centers, stroke centers, and ECG networks. It is a Hubei Provincial Enterprise Technology Center and a Wuhan Municipal Enterprise R&D Center. As a domestic advocate for high-throughput POCT, the company is a builder of chest pain centers, stroke centers, and remote ECG networks. Its main business currently covers nearly 5,000 medical institutions across 30 provinces, municipalities, and autonomous regions nationwide, while also establishing sales presence in Asia, the European Union, South America, and other regions. The company was listed on the Shenzhen Stock Exchange on July 10, 2018, under stock code 002932. During the fight against the COVID-19 pandemic, EasyDiagnosis successfully developed a COVID-19 nucleic acid detection kit and obtained relevant certifications, demonstrating its responsibility as an IVD enterprise in the affected area. Meanwhile, EasyDiagnosis's COVID-19 nucleic acid reagent, antibody detection reagent, and blood gas analyzer have also obtained EU CE certification, granting it permission to sell abroad.
EasyDiagnosis has successively passed EU CE certification and ISO 13485 quality management system certification. It holds over 30 CFDA-registered POCT rapid diagnostic reagent products, enabling rapid whole-blood bedside testing for PCT (procalcitonin) and S100-β protein. Its product portfolio covers cardiovascular and cerebrovascular diseases, infectious diseases, kidney diseases, diabetes, health checkups, and obstetrics and gynecology, making it one of the domestic companies with a relatively rich POCT product line.
The immunoquantitative detection platform independently developed by EasyDiagnosis enables one-step operation, intelligent identification, and rapid test results within 15 minutes, while also being compatible with the detection of nearly 30 immune markers. It is suitable not only for rapid bedside diagnosis of acute and critical conditions in large and medium-sized hospitals, but also for immunoquantitative analysis in the clinical laboratory departments of small and medium-sized hospitals, as well as for point-of-care testing of common diseases in primary-level hospitals. Currently, more than 3,000 medical institutions nationwide use EasyDiagnosis's POCT products, with over 60% being secondary-level hospitals or above.
Since 2017, EasyDiagnosis has successively launched a fully automated immunoquantitative analyzer, a 12-lead mobile electrocardiograph (for remote ECG network construction), the HB1000 glycated hemoglobin analyzer, the fully automated chemiluminescence platform SMART300, the whole-blood POCT chemiluminescence platform CF10, dozens of chemiluminescence reagents, the dry-type blood gas analysis platform ST2000, the wet-type blood gas analysis platform PT1000, and multiple molecular diagnostic reagents.
EasyDiagnosis's layout in the rapid diagnostics field fully aligns with the detection needs for acute and critical conditions in medical institutions, achieving multi-scenario coverage including in-hospital, central hospitals, primary-level hospitals, and pre-hospital emergency care. It has also established a comprehensive, scientific, and standardized quality control system. In response to and in implementation of the National Health and Family Planning Commission's requirements and standards for chest pain center construction, EasyDiagnosis has focused on developing integrated solutions for chest pain centers, helping medical institutions shorten the treatment time for patients with acute chest pain in the region and improve the treatment rate for patients with acute myocardial infarction.
EasyDiagnosis has an independent R&D center and a highly skilled R&D team. Its founders are outstanding representatives of the "Optics Valley 3551 Talent Program", with overseas study backgrounds and rich clinical experience, and hold multiple patented technologies. In 2016, EasyDiagnosis, in collaboration with Huazhong University of Science and Technology and Southeast University, obtained a national "Major Scientific Instrument and Equipment Development" special project from the Ministry of Science and Technology. EasyDiagnosis has repeatedly received honors such as being a valuable investment enterprise on the New Third Board, being selected for the list of enterprises with investment potential, the Forbes Potential List, the Gazelle Enterprise list, the Top 100 Influential Chinese Pharmaceutical Enterprises, and being recognized as one of the top ten POCT brands by laboratory professionals. EasyDiagnosis will continue to provide high-quality products and services for human health, striving to become a leading enterprise that offers innovative products and services to medical institutions.

Joining EasyDiagnosis, you will receive:
1. Competitive compensation within the industry, with opportunities for salary adjustment and promotion annually;
2. Five-day, eight-hour work system, with weekends off, and enjoy marriage leave, maternity leave, bereavement leave, and statutory holidays;
3. Social insurance and housing fund, providing security for employees' lives;
4. Free lunch, free shuttle bus to and from work, and free physical examination;
5. Traditional holiday condolences, as well as marriage and childbirth gifts, and sympathy and solatium payments;
6. Regularly organized outdoor activities and gatherings to enrich employees' leisure life.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

EasyDiagnosis Financing History (1 rounds)

Manage
IPO上市
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market: 主板
  • Deal: 深交所

EasyDiagnosis How Fast Is Hiring Growing? (34 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Down 1%
  • 2024: Down 61%
  • 2023: Up 18%
  • 2022: Down 22%
EasyDiagnosis Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
EasyDiagnosis Campus Recruitment & Advanced Degree Talent Demand
Master's 4
Note: How fast is hiring at Wuhan EasyDiagnosis Biomedicine Co., Ltd. growing? EasyDiagnosis2026: 127 openings (up 2%), 2025: 125 openings (down 1%), 2024: 126 openings (down 61%), 2023: 327 openings (up 18%), 2022: 276 openings (down 22%), 2021: 353 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

EasyDiagnosis Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Down 72%
  • 2024: Down 40%
  • 2023: Up 40%
  • 2022: Up 500%
EasyDiagnosis Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Wuhan EasyDiagnosis Biomedicine Co., Ltd. growing? EasyDiagnosisMaster's recruitment over the years: 2025: 7 openings (down 72%), 2024: 25 openings (down 40%), 2023: 42 openings (up 40%), 2022: 30 openings (up 500%), 2021: 5 openings.

EasyDiagnosis R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Wuhan EasyDiagnosis Biomedicine Co., Ltd.? Based on an analysis of EasyDiagnosis's job postings over the past year, "Electronics/Electrical/Communication Technology" demand: 8.4%, "Other (R&D and Technical)": 5.6%, "Computer/Network/Technology": 3.5%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 2.1%, "Mechanical/Instrumentation": 1.4%, "Medical & Health/Beauty & Healthcare": 0.7%. For reference only.

EasyDiagnosis — What Are the Salaries Like? (143 records)

Manage
salary range: 3K - 50K, 54.6% of roles pay ¥10-20K
Note: salary statistics are based on 143 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Wuhan EasyDiagnosis Biomedicine Co., Ltd.?EasyDiagnosis54.6% of positions earn 10-20K, Fresh graduate salary: ¥11.3K。Wuhan salary ranking top 25,销售类 average salary ¥12.7K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of EasyDiagnosis

(More)
Are salaries high at Wuhan EasyDiagnosis Biomedicine Co., Ltd.? We provide: Sales, Provincial Manager, Legal Counsel, Auditor, Accountant, R&D Engineer, Finance Specialist, Senior Specialist, Regional General Manager, 合规, Marketing, Production Technician, 税务, Software Engineer, Risk Control Specialist, C++ Developer, Analyst, Vice President, Regional Manager, Development Engineer. Click to view detailed salary analysis by job.

EasyDiagnosis — Fortune 500? (More)

Yes, ranked in 中国新经济500强:

  • NO.470 2022中国新经济500强 >

Yes, ranked in 中国高新技术企业慈善公益500强:

  • NO.340 2023中国高新技术企业慈善公益500强 >
  • NO.254 2022中国高新技术企业慈善公益500强 >

EasyDiagnosis honors, qualifications & industry associations

Job Category

  • 销售类
    48.4% of total 48.4%
  • 客户服务类
    32.1% of total 32.1%
  • 经营管理类
    31.4% of total 31.4%
  • 财务/审计/统计类
    17% of total 17%

Education

  • 本科
    79.9% of total 79.9%
  • 不限
    10.1% of total 10.1%
  • 硕士
    5.7% of total 5.7%
  • 大专
    3.8% of total 3.8%

Experience

  • 不限
    34.6% of total 34.6%
  • 5-10年
    28.9% of total 28.9%
  • 3-5年
    28.3% of total 28.3%
  • 1-3年
    6.3% of total 6.3%
View Detailed Analysis

What does Wuhan EasyDiagnosis Biomedicine Co., Ltd. require? Who is EasyDiagnosis hiring? EasyDiagnosis recruitment: 销售类占比最多占48.4%,其次是客户服务类占32.1%. What education can get in at EasyDiagnosis? 本科占比最多占79.9%,其次是不限占10.1%. High education required at EasyDiagnosis? 硕士占5.7%,博士占0.6%. Work experience required at EasyDiagnosis? 不限占比最多占34.6%,其次是5-10年占28.9%. Where are the job locations at EasyDiagnosis? 武汉占比最多占69.2%,其次是长沙占8.2%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 23,252.0957万(元)
Legal Representative: 陈莉莉
Date Established:
Credit Code: 9142010066953862X0
Registered Address: 湖北省武汉市东湖新技术开发区九龙中路77号武汉明德生物科技产业园(一期)(全部自用)1栋1单元1层1号C区

Partners & Suppliers

新冠检测试剂战略供应合作 Source
合作客户 战略合作
凯实生物为其提供IVD仪器 Source
供应商 体外诊断仪器客户
采购测序仪及测序相关设备,共同开发分子诊断应用 Source
供应商 基因测序设备
基于华为云平台打造智慧医疗解决方案 Source
供应商 云服务/IaaS
诊断试剂分销 Source
合作客户 医疗器械分销

People who follow EasyDiagnosis also follow

EasyDiagnosis Competitors (Similar Companies)

“Committed to providing green, safe, affordable and abundant biopharmac”
“Leading enterprise in Hubei pharmaceutical industry, one of China's to”
“Trustworthy biological experiment service provider”
“Providing antibody drug R&D and production contract services for inter”
“A technology-driven international pharmaceutical enterprise”
“Serve humanity with biotechnology and make human life better.”
动力电池 充电电池 电池 储能电池
集成电路制造 存储器 集成电路/IC 半导体
“A professional company dedicated to the design, procurement, and const”
医用材料 生物材料 医疗器械 生物活性材料
“It is a large high-tech enterprise integrating production, education, ”
“Let everyone in the world enjoy a better life through technology”
“To develop high-quality biologics that are accessible and affordable f”
“Supplier of optical fibre preforms, optical fibres, and optical cables”
“Focusing on the research and development, production, sales of veterin”

Discover Great Companies, Discover Great Clients

武汉公司名录 武汉“East Lake High-tech Zone”公司名录 武汉“生物制品”公司名录 武汉“生物化学”公司名录 武汉“试剂”公司名录 武汉“生物科技/生物工程”公司名录 武汉“诊断试剂”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates